Norges Bank
TGTX icon

Norges Bank’s TG Therapeutics TGTX Stock Holding History

Norges Bank’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-89,820
Closed -$3.23M – 1415
2025
Q2 		$3.23M Sell
89,820
-128,526
-59% -$4.78M ﹤0.01% 1375
2025
Q1 		$8.61M Sell
218,346
-183,149
-46% -$6.16M ﹤0.01% 1296
2024
Q4 		$12.1M Sell
401,495
-35,969
-8% -$1.03M ﹤0.01% 1322
2024
Q3 		$10.2M Sell
437,464
-159,836
-27% -$3.49M ﹤0.01% 1357
2024
Q2 		$10.6M Sell
597,300
-114,390
-16% -$1.83M ﹤0.01% 1379
2024
Q1 		$10.8M Sell
711,690
-363,347
-34% -$5.79M ﹤0.01% 1425
2023
Q4 		$18.4M Buy
1,075,037
+152,925
+17% +$1.78M ﹤0.01% 1309
2023
Q3 		$7.71M Hold
922,112
– – ﹤0.01% 1564
2023
Q2 		$22.9M Sell
922,112
-21,057
-2% -$544K ﹤0.01% 1198
2023
Q1 		$14.2M Sell
943,169
-191,923
-17% -$2.92M ﹤0.01% 1431
2022
Q4 		$13.4M Hold
1,135,092
– – ﹤0.01% 1453
2022
Q3 		$6.72M Buy
1,135,092
+68,493
+6% +$449K ﹤0.01% 1667
2022
Q2 		$4.53M Buy
1,066,599
+51,177
+5% +$320K ﹤0.01% 1792
2022
Q1 		$9.66M Sell
1,015,422
-7,500
-0.7% -$86.8K ﹤0.01% 1715
2021
Q4 		$19.4M Buy
1,022,922
+198,098
+24% +$5.14M ﹤0.01% 1495
2021
Q3 		$27.4M Sell
824,824
-293,959
-26% -$9.09M 0.01% 1276
2021
Q2 		$43.4M Buy
1,118,783
+46,937
+4% +$1.84M 0.01% 1054
2021
Q1 		$51.7M Sell
1,071,846
-203,647
-16% -$9.78M 0.01% 949
2020
Q4 		$66.4M Buy
1,275,493
+15,083
+1% +$510K 0.02% 790
2020
Q3 		$33.7M Buy
1,260,410
+1,240,410
+6,202% +$28.5M 0.01% 1084
2020
Q2 		$390K Buy
+20,000
New +$322K ﹤0.01% 2058
2019
Q2 		– Sell
-100,000
Closed -$804K – 2129
2019
Q1 		$804K Buy
+100,000
New +$540K ﹤0.01% 2062

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank's TGTX Position: Q3 2025 in Review

Norges Bank sold out of TG Therapeutics (TGTX) in Q3 2025, closing a stake of 89,820 shares — an estimated $3.23M sold.

Norges Bank first reported a position in TGTX in Q1 2019 and held it in 22 quarters. The position peaked at $66.4M in Q4 2020. 354 funds tracked by Wall St. Rank hold TGTX as of Q3 2025.

  • Norges Bank reported no remaining TG Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Norges Bank sold 89,820 TG Therapeutics shares in Q3 2025, an estimated $3.23M.
  • Norges Bank first reported a position in TG Therapeutics in Q1 2019 and held it in 22 quarters.
  • Norges Bank's TG Therapeutics position peaked at $66.4M in Q4 2020.
  • 354 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2025.

Based on Norges Bank's 13F filing for Q3 2025.